Breast lumps differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 39: | Line 39: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+Differential diagnosis of breast lumps | |+Differential diagnosis of breast lumps | ||
!style="background:#DCDCDC;" align="center" + |[[Benign]] | ! style="background:#DCDCDC;" align="center" + |[[Benign]] | ||
|style="background:#F5F5F5;" + |Palpable breast masses in women between 20 to 50 years old<ref name="pmid9545356">{{cite journal| author=Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW| title=Ten-year risk of false positive screening mammograms and clinical breast examinations. | journal=N Engl J Med | year= 1998 | volume= 338 | issue= 16 | pages= 1089-96 | pmid=9545356 | doi=10.1056/NEJM199804163381601 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9545356 }}</ref>The most common types of benign breast lumps are<ref name="pmid10794579">{{cite journal| author=Morrow M| title=The evaluation of common breast problems. | journal=Am Fam Physician | year= 2000 | volume= 61 | issue= 8 | pages= 2371-8, 2385 | pmid=10794579 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10794579 }}</ref>: | | style="background:#F5F5F5;" + |Palpable breast masses in women between 20 to 50 years old<ref name="pmid9545356">{{cite journal| author=Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW| title=Ten-year risk of false positive screening mammograms and clinical breast examinations. | journal=N Engl J Med | year= 1998 | volume= 338 | issue= 16 | pages= 1089-96 | pmid=9545356 | doi=10.1056/NEJM199804163381601 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9545356 }}</ref>The most common types of benign breast lumps are<ref name="pmid10794579">{{cite journal| author=Morrow M| title=The evaluation of common breast problems. | journal=Am Fam Physician | year= 2000 | volume= 61 | issue= 8 | pages= 2371-8, 2385 | pmid=10794579 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10794579 }}</ref>: | ||
*[[Fibroadenoma]] | *[[Fibroadenoma]] | ||
*[[Cysts]] | *[[Cysts]] | ||
Line 48: | Line 48: | ||
*[[Breast abscess]] | *[[Breast abscess]] | ||
|- | |- | ||
!style="background:#DCDCDC;" align="center" + |[[Malignant]] | ! style="background:#DCDCDC;" align="center" + |[[Malignant]] | ||
|style="background:#F5F5F5;" + |The most common types are infiltrating ductal [[breast carcinoma]], infiltrating lobular [[breast carcinoma]], mixed of ductal and lobular carcinoma and usually present as a hard mass in breast<ref name="pmid115491572">{{cite journal| author=Schoonjans JM, Brem RF| title=Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses. | journal=J Ultrasound Med | year= 2001 | volume= 20 | issue= 9 | pages= 967-72 | pmid=11549157 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11549157 }}</ref> | | style="background:#F5F5F5;" + |The most common types are infiltrating ductal [[breast carcinoma]], infiltrating lobular [[breast carcinoma]], mixed of ductal and lobular carcinoma and usually present as a hard mass in breast<ref name="pmid115491572">{{cite journal| author=Schoonjans JM, Brem RF| title=Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses. | journal=J Ultrasound Med | year= 2001 | volume= 20 | issue= 9 | pages= 967-72 | pmid=11549157 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11549157 }}</ref> | ||
|} | |} | ||
==Differentiating Breast lumps from other Diseases== | ==Differentiating Breast lumps from other Diseases== | ||
Line 57: | Line 57: | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! | |||
! | |||
! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestation | ! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestation | ||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Paraclinical findings | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Paraclinical findings | ||
Line 62: | Line 64: | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! | |||
! | |||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ||
Line 69: | Line 73: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | !Benign | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | !Malignant | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Secretion | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Finding 1 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Finding 1 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Finding 2 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Finding 2 | ||
Line 79: | Line 85: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
! | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! align="center" style="background:#DCDCDC;" | | ! align="center" style="background:#DCDCDC;" |Fibroadenoma | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
| | |||
| | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! | ! | ||
![[Phyllodes tumor]] | |||
! | |||
! | |||
! | |||
! | |||
| | ! | ||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|- | |||
! | |||
! align="center" style="background:#DCDCDC;" |Breast cyst | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | |||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! | ! | ||
! align="center" style="background:#DCDCDC;" | | ! align="center" style="background:#DCDCDC;" |Fibrocystic change | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | |||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" | | ! | ||
! align="center" style="background:#DCDCDC;" |Galactocele | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | |||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! | ! | ||
! align="center" style="background:#DCDCDC;" | | ! align="center" style="background:#DCDCDC;" |Fat necrosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | |||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 171: | Line 205: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" | | ! | ||
! align="center" style="background:#DCDCDC;" |Breast abscess | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| | |||
| | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 187: | Line 224: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |||
! | |||
!Breast cancer | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
! | |||
|} | |} | ||
Revision as of 16:34, 12 January 2019
Breast lumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Breast lumps differential diagnosis On the Web |
American Roentgen Ray Society Images of Breast lumps differential diagnosis |
Risk calculators and risk factors for Breast lumps differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps.
Breast symptoms such as nipple discharge and mastalgia require assessment as well [1].
Differentiating Breast lumps from other Diseases
Differential diagnosis of breast lumps include: [1]
- Malignancy or breast cancer
- Associated with following factors[2]:
- Geographical area
- Age
- Ethnicity
- Positive family history
- Pathology results such as:
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Lobular carcinoma in situ (LCIS)
- Previous history of radiotherapy
- Associated with following factors[2]:
- Inflammatory lumps:[3][4]
- Associated to personal habit and disease pattern:
- Infective lumps
- Non-infective lumps such as chronic granulomatous infection
- Associated to personal habit and disease pattern:
- Solid non-inflammatory lumps [5] [6]
- Related to age, geographical area and ethnicity
- Mostly fibroadenomas in women aged 20-30 years
- Phyllodes tumor are prevalent in various centers, racial groups in different frequencies
- Cysts[7]
- Related to age and usage of hormonal replacement therapy
- Symptomatic cysts are often seen in women age 30 years to early 50 years
- If menopausaed women may be present due to hormone replacement therapy (HRT)
Benign | Palpable breast masses in women between 20 to 50 years old[8]The most common types of benign breast lumps are[9]:
|
---|---|
Malignant | The most common types are infiltrating ductal breast carcinoma, infiltrating lobular breast carcinoma, mixed of ductal and lobular carcinoma and usually present as a hard mass in breast[10] |
Differentiating Breast lumps from other Diseases
Category | Diseases | Etiology | Clinical manifestation | Paraclinical findings | Gold standard diagnosis | Associated findings | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab findings | Imaging | |||||||||||||
Benign | Malignant | Mass | Pain | Secretion | Finding 1 | Finding 2 | Others | Finding 1 | Finding 2 | Histopathology | ||||||||
Fibroadenoma | ||||||||||||||||||
Phyllodes tumor | ||||||||||||||||||
Breast cyst | ||||||||||||||||||
Fibrocystic change | ||||||||||||||||||
Galactocele | ||||||||||||||||||
Fat necrosis | ||||||||||||||||||
Breast abscess | ||||||||||||||||||
Breast cancer |
References
- ↑ 1.0 1.1 Cheung KL, Lam TP (2005). "Approach to a lump in the breast: a regional perspective". Asian J Surg. 28 (1): 65–70. doi:10.1016/S1015-9584(09)60264-5. PMID 15691804.
- ↑ Collyar DE (2001). "Breast cancer: a global perspective". J Clin Oncol. 19 (18 Suppl): 101S–105S. PMID 11560983.
- ↑ Lang AP, Luchsinger IS, Rawling EG (1987). "Filariasis of the breast". Arch Pathol Lab Med. 111 (8): 757–9. PMID 3307689.
- ↑ Varghese R, Raghuveer CV, Pai MR, Bansal R (1996). "Microfilariae in cytologic smears: a report of six cases". Acta Cytol. 40 (2): 299–301. doi:10.1159/000333755. PMID 8629415.
- ↑ Alagaratnam, T.T. & Wong, J. World J. Surg. (1989) 13: 743. https://doi.org/10.1007/BF01658425
- ↑ Shukla HS, Kumar S (1989). "Benign breast disorders in nonwestern populations: Part II--Benign breast disorders in India". World J Surg. 13 (6): 746–9. PMID 2623884.
- ↑ Leung TN, Haines CJ, Chung TK (2001). "Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong". Maturitas. 39 (3): 195–201. PMID 11574178.
- ↑ Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998). "Ten-year risk of false positive screening mammograms and clinical breast examinations". N Engl J Med. 338 (16): 1089–96. doi:10.1056/NEJM199804163381601. PMID 9545356.
- ↑ Morrow M (2000). "The evaluation of common breast problems". Am Fam Physician. 61 (8): 2371–8, 2385. PMID 10794579.
- ↑ Schoonjans JM, Brem RF (2001). "Fourteen-gauge ultrasonographically guided large-core needle biopsy of breast masses". J Ultrasound Med. 20 (9): 967–72. PMID 11549157.